Vertex Pharmaceuticals Inc (VRTX)
471.12
-4.86
(-1.02%)
USD |
NASDAQ |
Nov 01, 16:00
471.00
-0.12
(-0.03%)
After-Hours: 20:00
Vertex Pharmaceuticals Price to Book Value: 8.230 for Nov. 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 8.230 |
| October 31, 2024 | 8.315 |
| October 30, 2024 | 8.299 |
| October 29, 2024 | 8.217 |
| October 28, 2024 | 8.322 |
| October 25, 2024 | 8.345 |
| October 24, 2024 | 8.244 |
| October 23, 2024 | 8.211 |
| October 22, 2024 | 8.296 |
| October 21, 2024 | 8.352 |
| October 18, 2024 | 8.438 |
| October 17, 2024 | 8.712 |
| October 16, 2024 | 8.512 |
| October 15, 2024 | 8.460 |
| October 14, 2024 | 8.469 |
| October 11, 2024 | 8.415 |
| October 10, 2024 | 8.318 |
| October 09, 2024 | 8.175 |
| October 08, 2024 | 8.017 |
| October 07, 2024 | 7.837 |
| October 04, 2024 | 7.954 |
| October 03, 2024 | 7.923 |
| October 02, 2024 | 8.073 |
| October 01, 2024 | 8.206 |
| September 30, 2024 | 8.125 |
| Date | Value |
|---|---|
| September 27, 2024 | 8.086 |
| September 26, 2024 | 8.091 |
| September 25, 2024 | 8.067 |
| September 24, 2024 | 8.088 |
| September 23, 2024 | 8.036 |
| September 20, 2024 | 8.122 |
| September 19, 2024 | 8.348 |
| September 18, 2024 | 8.283 |
| September 17, 2024 | 8.407 |
| September 16, 2024 | 8.55 |
| September 13, 2024 | 8.479 |
| September 12, 2024 | 8.362 |
| September 11, 2024 | 8.293 |
| September 10, 2024 | 8.224 |
| September 09, 2024 | 8.230 |
| September 06, 2024 | 8.176 |
| September 05, 2024 | 8.186 |
| September 04, 2024 | 8.360 |
| September 03, 2024 | 8.310 |
| August 30, 2024 | 8.663 |
| August 29, 2024 | 8.618 |
| August 28, 2024 | 8.555 |
| August 27, 2024 | 8.390 |
| August 26, 2024 | 8.431 |
| August 23, 2024 | 8.407 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.758
Minimum
Oct 05 2021
11.87
Maximum
Jun 23 2020
6.937
Average
6.200
Median
Price to Book Value Benchmarks
| Eli Lilly and Co | 54.59 |
| Bristol-Myers Squibb Co | 6.427 |
| Regeneron Pharmaceuticals Inc | 3.161 |
| Sarepta Therapeutics Inc | 10.92 |
| Moderna Inc | 1.793 |
Price to Book Value Related Metrics
| PS Ratio | 11.86 |
| Price | 471.12 |
| Earnings Yield | -0.43% |
| Market Cap | 121.60B |
| Operating PE Ratio | 29.19 |
| Normalized PE Ratio | 39.54 |